Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436

Watchlist Manager
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Logo
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Watchlist
Price: 218 CNY -1.13% Market Closed
Market Cap: 131.5B CNY
Have any thoughts about
Zhangzhou Pientzehuang Pharmaceutical Co Ltd?
Write Note

Relative Value

The Relative Value of one Zhangzhou Pientzehuang Pharmaceutical Co Ltd stock under the Base Case scenario is 169.35 CNY. Compared to the current market price of 218 CNY, Zhangzhou Pientzehuang Pharmaceutical Co Ltd is Overvalued by 22%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
169.35 CNY
Overvaluation 22%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
87
vs Industry
12
Median 3Y
18.3
Median 5Y
18.9
Industry
2.5
Forward
11.6
vs History
92
vs Industry
9
Median 3Y
64
Median 5Y
67.2
Industry
21.8
Forward
41.3
vs History
31
vs Industry
5
Median 3Y
61.1
Median 5Y
60.1
Industry
16.1
vs History
33
vs Industry
9
Median 3Y
62.2
Median 5Y
61.1
Industry
23.8
vs History
90
vs Industry
7
Median 3Y
14.2
Median 5Y
14.8
Industry
2.1
vs History
87
vs Industry
12
Median 3Y
17.8
Median 5Y
18.7
Industry
2.7
Forward
10.9
vs History
88
vs Industry
7
Median 3Y
39.6
Median 5Y
40.6
Industry
5.2
vs History
92
vs Industry
9
Median 3Y
53.4
Median 5Y
57.5
Industry
13.5
Forward
32.1
vs History
92
vs Industry
11
Median 3Y
53.4
Median 5Y
57.5
Industry
16.8
Forward
33.1
vs History
31
vs Industry
7
Median 3Y
57.7
Median 5Y
57
Industry
15.2
vs History
33
vs Industry
6
Median 3Y
61.1
Median 5Y
60.3
Industry
19.3
vs History
68
vs Industry
6
Median 3Y
20.7
Median 5Y
21.9
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
131.5B CNY 12.1 42.7 35 35
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
756.3B USD 18.5 90.4 48.5 54.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 10.2 29 20.2 23
US
Johnson & Johnson
NYSE:JNJ
349.7B USD 4 23.8 11.5 15
US
Merck & Co Inc
NYSE:MRK
251.6B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
199.5B CHF 3.4 17.3 9.8 11.6
UK
AstraZeneca PLC
LSE:AZN
161.6B GBP 4.1 31.4 168.9 253.1
CH
Novartis AG
SIX:NOVN
171.3B CHF 3.8 10.8 9.4 13.1
US
Pfizer Inc
NYSE:PFE
151.4B USD 2.5 35.6 10.6 16
P/E Multiple
Earnings Growth P/E to Growth
CN
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Average P/E: 33.5
42.7
52%
0.8
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
90.4
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.8
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.7
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.3
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.4
177%
0.2
CH
Novartis AG
SIX:NOVN
10.8
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.6
719%
0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Average EV/EBITDA: 417.1
35
58%
0.6
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.5
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.2
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.5
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.5
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
168.9
64%
2.6
CH
Novartis AG
SIX:NOVN
9.4
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.6
31%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Average EV/EBIT: 1 813.6
35
52%
0.7
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.2
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
15
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.5
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.1
131%
1.9
CH
Novartis AG
SIX:NOVN
13.1
58%
0.2
US
Pfizer Inc
NYSE:PFE
16
68%
0.2

See Also

Discover More
Back to Top